Goldman Sachs’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,153,979
Closed -$33.1M 6610
2025
Q4
$33.1M Buy
2,153,979
+291,423
+16% +$3.21M ﹤0.01% 1867
2025
Q3
$18.5M Buy
1,862,556
+220,173
+13% +$2.29M ﹤0.01% 2340
2025
Q2
$16.3M Buy
1,642,383
+331,275
+25% +$3.49M ﹤0.01% 2310
2025
Q1
$17M Sell
1,311,108
-1,495,207
-53% -$19.8M ﹤0.01% 2179
2024
Q4
$35.8M Sell
2,806,315
-1,485,513
-35% -$18M 0.01% 1580
2024
Q3
$47.8M Sell
4,291,828
-461,560
-10% -$5.09M 0.01% 1282
2024
Q2
$53.4M Buy
4,753,388
+581,969
+14% +$6.77M 0.01% 1122
2024
Q1
$51.8M Buy
4,171,419
+574,280
+16% +$7.49M 0.01% 1145
2023
Q4
$50.3M Buy
3,597,139
+644,428
+22% +$8.95M 0.01% 1186
2023
Q3
$43.6M Sell
2,952,711
-639,556
-18% -$8.99M 0.01% 1178
2023
Q2
$46.4M Sell
3,592,267
-105,985
-3% -$1.21M 0.01% 1164
2023
Q1
$36.3M Buy
3,698,252
+2,107,157
+132% +$22.5M 0.01% 1300
2022
Q4
$16.9M Buy
1,591,095
+216,009
+16% +$2.51M ﹤0.01% 2108
2022
Q3
$14.4M Sell
1,375,086
-366,139
-21% -$4.77M ﹤0.01% 2160
2022
Q2
$21.9M Sell
1,741,225
-439,503
-20% -$4.67M 0.01% 1822
2022
Q1
$23.6M Buy
2,180,728
+342,361
+19% +$4.16M 0.01% 1923
2021
Q4
$25.9M Buy
1,838,367
+747,533
+69% +$12.3M 0.01% 1900
2021
Q3
$21M Sell
1,090,834
-701,643
-39% -$9.32M ﹤0.01% 2027
2021
Q2
$17.7M Sell
1,792,477
-1,481,483
-45% -$13.5M ﹤0.01% 2158
2021
Q1
$32.2M Buy
3,273,960
+1,239,062
+61% +$10.2M 0.01% 1527
2020
Q4
$9.05M Buy
2,034,898
+1,276,851
+168% +$5.78M ﹤0.01% 2555
2020
Q3
$3.27M Buy
758,047
+200,815
+36% +$1.43M ﹤0.01% 3223
2020
Q2
$4.94M Sell
557,232
-828,741
-60% -$4.19M ﹤0.01% 2810
2020
Q1
$4.89M Buy
1,385,973
+1,161,740
+518% +$5.39M ﹤0.01% 2666
2019
Q4
$1.28M Buy
224,233
+47,038
+27% +$251K ﹤0.01% 3959
2019
Q3
$633K Sell
177,195
-93,939
-35% -$364K ﹤0.01% 4320
2019
Q2
$1.08M Sell
271,134
-63,999
-19% -$371K ﹤0.01% 3941
2019
Q1
$2.45M Buy
335,133
+79,031
+31% +$773K ﹤0.01% 3491
2018
Q4
$2.34M Sell
256,102
-4,235
-2% -$46.9K ﹤0.01% 3427
2018
Q3
$3.23M Sell
260,337
-22,740
-8% -$308K ﹤0.01% 3280
2018
Q2
$4.32M Buy
283,077
+95,688
+51% +$1.65M ﹤0.01% 3057
2018
Q1
$3.72M Buy
187,389
+20,155
+12% +$348K ﹤0.01% 3130
2017
Q4
$3.13M Sell
167,234
-378,712
-69% -$7.6M ﹤0.01% 3405
2017
Q3
$11.7M Buy
545,946
+501,497
+1,128% +$7.93M ﹤0.01% 2440
2017
Q2
$429K Sell
44,449
-11,415
-20% -$74.1K ﹤0.01% 5214
2017
Q1
$332K Sell
55,864
-344,627
-86% -$1.66M ﹤0.01% 5380
2016
Q4
$1.58M Sell
400,491
-483,265
-55% -$3.54M ﹤0.01% 4067
2016
Q3
$9.27M Buy
883,756
+402,954
+84% +$5.79M ﹤0.01% 2516
2016
Q2
$7.01M Buy
480,802
+50,136
+12% +$857K ﹤0.01% 2587
2016
Q1
$8.29M Sell
430,666
-63,316
-13% -$1.28M ﹤0.01% 2368
2015
Q4
$11.9M Buy
493,982
+371,479
+303% +$9.31M ﹤0.01% 2117
2015
Q3
$3.01M Buy
122,503
+66,800
+120% +$1.89M ﹤0.01% 3378
2015
Q2
$1.3M Buy
55,703
+21,948
+65% +$478K ﹤0.01% 4281
2015
Q1
$757K Buy
+33,755
New +$647K ﹤0.01% 4738
2014
Q4
Sell
-49,675
Closed -$711K 7150
2014
Q3
$711K Buy
49,675
+43,934
+765% +$633K ﹤0.01% 4956
2014
Q2
$91K Sell
5,741
-8,361
-59% -$126K ﹤0.01% 6590
2014
Q1
$255K Sell
14,102
-12,039
-46% -$223K ﹤0.01% 5862
2013
Q4
$513K Sell
26,141
-10,173
-28% -$149K ﹤0.01% 5277
2013
Q3
$432K Sell
36,314
-30,385
-46% -$382K ﹤0.01% 5262
2013
Q2
$734K Buy
+66,699
New +$1.41M ﹤0.01% 4634

Other funds holding DVAX

Goldman Sachs's DVAX Position: Q1 2026 in Review

Goldman Sachs sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 2,153,979 shares — an estimated $33.1M sold.

Goldman Sachs first reported a position in DVAX in Q2 2013 and held it in 50 quarters. The position peaked at $53.4M in Q2 2024. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Goldman Sachs reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Goldman Sachs sold 2,153,979 Dynavax Technologies shares in Q1 2026, an estimated $33.1M.
  • Goldman Sachs first reported a position in Dynavax Technologies in Q2 2013 and held it in 50 quarters.
  • Goldman Sachs's Dynavax Technologies position peaked at $53.4M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.